Research peptides

TR is a dual GIP/GLP-1 receptor agonist developed by Eli Lilly. Its twin-incretin pharmacology has generated significant research interest in metabolic disease, covering insulin secretion, glucagon suppression, gastric emptying, and adipose tissue biology.

RT (LY3437943) is a triple GIP/GLP-1/glucagon receptor agonist. Its tri-agonist mechanism enables research into simultaneous incretin activity and enhanced energy expenditure, making it a leading compound in next-generation metabolic disorder studies.

RT (LY3437943) is a triple GIP/GLP-1/glucagon receptor agonist supplied in a higher 60 mg research presentation. Its tri-agonist mechanism enables research into simultaneous incretin activity and enhanced energy expenditure, making it a leading compound in next-generation metabolic disorder studies.

Klow is a research blend of TB-500, BPC-157, GHK-Cu, and KPV. This four-compound formulation combines angiogenic, anti-inflammatory, and collagen-promoting peptides to study multi-pathway approaches to tissue repair and dermal regeneration.

Glow is a proprietary research blend combining TB-500, BPC-157, and GHK-Cu. This combination is studied for synergistic tissue regeneration, angiogenesis promotion, and antioxidant properties in wound healing and skin biology research.

MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded within the 12S rRNA region of the mitochondrial genome. Research has explored its roles in metabolic homeostasis, insulin sensitivity, AMPK activation, exercise capacity, and adaptation to metabolic stress, positioning it as a leading compound in mitochondrial biology studies.

Tesamorelin is a synthetic 44-amino-acid analogue of growth hormone-releasing hormone (GHRH) developed by Theratechnologies. Research has examined its ability to stimulate pulsatile endogenous growth hormone secretion, with studies covering visceral adipose tissue reduction, lipid metabolism, IGF-1 modulation, and cognitive endpoints in HIV-associated lipodystrophy and related models.

GHK-Cu (Copper Peptide) is a naturally occurring tripeptide-copper complex first isolated by Loren Pickart in 1973. Research has examined its roles in wound healing, collagen and elastin synthesis, angiogenesis, and antioxidant gene expression regulation.

GHK-Cu (Copper Peptide) is a naturally occurring tripeptide-copper complex first isolated by Loren Pickart in 1973. Research has examined its roles in wound healing, collagen and elastin synthesis, angiogenesis, and antioxidant gene expression regulation.

Melanotan I (afamelanotide) is a synthetic analogue of alpha-MSH developed at the University of Arizona. It activates melanocortin receptors to increase eumelanin production. Research has explored its role in photoprotection and pigmentation-related conditions.

Melanotan II is a cyclic lactam analogue of alpha-MSH. Beyond pigmentation, research has investigated its effects on sexual function via MC4R activation and appetite suppression via central melanocortin pathways.

Testosterone cypionate or 'Test C' is a mid to slow-acting ester of injectable testosterone. Similarly to Test E it was designed to provide a steady release of testosterone into the bloodstream once injected into muscle tissue.

Proactiv Mark Correcting Pads are pre-moistened towelettes formulated with glycolic acid. Each sealed packet contains a single-use pad designed for topical skincare routines targeting the appearance of post-blemish marks.